Advanced search
Start date
Betweenand


Jacobsen Catalyst as a Cytochrome P450 Biomimetic Model for the Metabolism of Monensin A

Full text
Author(s):
Show less -
Rocha, Bruno Alves ; Moraes de Oliveira, Anderson Rodrigo ; Pazin, Murilo ; Dorta, Daniel Junqueira ; Rodrigues, Andresa Piacezzi Nascimento ; Berretta, Andresa Aparecida ; Peti, Ana Paula Ferranti ; Beraldo de Moraes, Luiz Alberto ; Lopes, Norberto Peporine ; Pospisil, Stanislav ; Gates, Paul Jonathan ; Assis, Marilda das Dores
Total Authors: 12
Document type: Journal article
Source: BIOMED RESEARCH INTERNATIONAL; v. 2014, p. 8-pg., 2014-01-01.
Abstract

Monensin A is a commercially important natural product isolated from Streptomyces cinnamonensins that is primarily employed to treat coccidiosis. Monensin A selectively complexes and transports sodium cations across lipid membranes and displays a variety of biological properties. In this study, we evaluated the Jacobsen catalyst as a cytochrome P450 biomimetic model to investigate the oxidation of monensin A. Mass spectrometry analysis of the products from these model systems revealed the formation of two products: 3-O-demethyl monensin A and 12-hydroxy monensin A, which are the same ones found in in vivo models. Monensin A and products obtained in biomimetic model were tested in a mitochondrial toxicity model assessment and an antimicrobial bioassay against Staphylococcus aureus, S. aureus methicillin-resistant, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Escherichia coli. Our results demonstrated the toxicological effects of monensin A in isolated rat liver mitochondria but not its products, showing that the metabolism of monensin A is a detoxification metabolism. In addition, the antimicrobial bioassay showed that monensin A and its products possessed activity against Gram-positive microorganisms but not for Gram-negative microorganisms. The results revealed the potential of application of this biomimetic chemical model in the synthesis of drug metabolites, providing metabolites for biological tests and other purposes. (AU)

FAPESP's process: 11/05800-0 - Evaluation of Microbiological and Chemical Models for the Study of Bio(transformations) of Antibiotic Monensin A
Grantee:Bruno Alves Rocha
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 13/17658-9 - Development and validation of chromatographic and electrophoretic methods for subsequent application in studies of in vitro metabolism and biotransformation - phase 2
Grantee:Anderson Rodrigo Moraes de Oliveira
Support Opportunities: Regular Research Grants